Fevertree Drinks PLC (LON:FEVR – Get Free Report) insider Domenico De Lorenzo bought 44,674 shares of the company’s stock in a transaction dated Friday, September 11th. The stock was bought at an average price of GBX 780 per share, for a total transaction of £348,457.20.
Fevertree Drinks Stock Up 3.1%
FEVR opened at GBX 803.50 on Monday. The company has a debt-to-equity ratio of 1.89, a current ratio of 3.16 and a quick ratio of 3.21. The company’s 50-day moving average is GBX 830.05 and its 200 day moving average is GBX 820.84. Fevertree Drinks PLC has a fifty-two week low of GBX 711 and a fifty-two week high of GBX 973. The firm has a market capitalization of £895.94 million, a P/E ratio of 43.15, a PEG ratio of -4.51 and a beta of 1.14.
Fevertree Drinks (LON:FEVR – Get Free Report) last issued its quarterly earnings data on Thursday, September 10th. The company reported GBX 9.50 earnings per share (EPS) for the quarter. Fevertree Drinks had a net margin of 7.29% and a return on equity of 11.88%. Research analysts expect that Fevertree Drinks PLC will post 38.3184173 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on Fevertree Drinks
Fevertree Drinks Company Profile
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.
Featured Stories
- Five stocks we like better than Fevertree Drinks
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.
